The Board also discussed the goals and vision of the Paul and Diane Manning Institute of Biotechnology and voted to approve ...

UCLA Chancellor Julio Frenk, who was inaugurated Thursday, spoke to The Times about the state of higher education and his ...

The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...

Metallic nanoparticles injected into the retina partly restored vision in blind mice and could work as a treatment for ...

One in five adults in the U.S. lives with a mental illness. Two in five teens report struggling with depression. With numbers ...

Stem cells can fight disease from the inside out. But not all treatments are created equal. The promise of stem cell therapy ...

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

What we set out to do, and what we’ve continued working on, is exploring all the ways we could create the best possible ...

For people diagnosed with macular telangiectasia type 2 (MacTel)-a rare and slowly progressing retinal disease-there have ...

Sutter Health has broken ground on a five-story, 129,000-square-foot facility neuroscience complex in San Francisco that is expected to open in 2028. The facility will be designed as a regional hub ...

Annual Meeting held in Chicago, USA, from May 30 to June 3, the results of the Phase Ib/II clinical study of 9MW2821 in combination with Toripalimab for the treatment of patients with ...